Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients

Strahlentherapie und Onkologie

Volumn 175, Issue 11, 1999, Pages 554-558

  Huguenin, Pia U ^a   Bitterli, Marc ^a   Lütolf, Urs M ^a   Bernhard, Jürg ^b   Glanzmann, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Swiss Institute for Applied Cancer Research   (Switzerland)

Author keywords

Elderly patients; Late toxicity; Prostate cancer; Quality of life; Radiotherapy

Indexed keywords

AGED; ARTICLE; BLEEDING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROCTITIS; PROSTATE CANCER; QUALITY OF LIFE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0032752829     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000660050040     Document Type: Article

References (20)

1. Aaronson NK, Ahmedzai S, Bergman BBM, et al. The European Organisation tor Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993:85:365-76.
2. Adami H, Norlén BJ, Malker B, et al. Long-term survival in prostatic carcinoma, with special reference to age as prognostic factor. Scand J Urol Nephrol 1986;20:107-12.
3. Aus G. Prostate cancer: mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment. Scand J Urol Nephrol 1994;167:Suppl:1-41.
4. International Union Against Cancer. Prostate (ICD-O 185). In: Hermanek P. Sobin LH. TNM classification of malignant tumours, 4th edn. Berlin-Heidelberg-New York: Springer, 1987:124-6.
5. Catalona W. Management of cancer of the prostate. N Engl J Med 1994:331:996-1004.
6. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330:242-8.
7. Fleming C, Wasson JH, Albertsen PC, et al. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993:269:2650-8.
8. Grönberg H, Damber J, Jonsson H, et al. Patient age as a prognostic factor in prostate cancer. J Urol 1994:152:892-5.
9. The Medical Research Counsil Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Counsil trial. Br J Urol 1997:79:235-46.
10. Hanks GE, Hanlon A, Owen JB, et al. Patterns of radiation treatment of elderly patients with prostate cancer. Cancer 1994;74:2174-7.
11. Huguenin P, Glanzmann C, Lütolf UM. Acute toxicity of curative radiotherapy in elderly patients. Strahlenther Onkol 1996;172:658-63.
12. Levi F, Raymond I., Schüler G, Krebs in der Schweiz. Bern: Schweiz Krebsliga, 1996:31-2.
13. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995:273:129-35.
14. Madsen PO, Graversen PH, Gasser TC, et al. Treatment of localized prostatic cancer. Radical prostatectomy versus placebo. A 15-year follow-up. Scand J Urol Nephrol 1988; 110:Suppl:95-100.
15. Mettlin C. Recent developments in the epidemiology of prostate cancer. Eur J Cancer 1997;33:340-7.
16. Pignon T, Horiot JC, Bolla M, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 1997;42:107-20.
17. Schüler G. Data from the Cancer Registry of the Canton of Zurich. Unpublished, 1996.
18. Seegensehmiedt MH, Sauer R. Systematik der akuten und chronischen Strahlenfolgen. Strahlenther Onkol 1993;169:83-95.
19. Steffen H, Cipriani J, Oglesby S, et al. Schweizerische Sterbetafel. Amtliche Statistik der Schweiz 1988:59-85.
20. Zagars G, von Eschenbach A, Ayala A, et al. The influence of local control on metastatic dissemination of prostate cancel treated by external beam megavoltage therapy. Cancer 1991;68:2370-7.